{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,6]],"date-time":"2026-09-06T17:39:46Z","timestamp":1788716386193,"version":"build-2803163510"},"reference-count":49,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2016,11,11]],"date-time":"2016-11-11T00:00:00Z","timestamp":1478822400000},"content-version":"vor","delay-in-days":680,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["P20MD003942"],"award-info":[{"award-number":["P20MD003942"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006545","name":"National Institute of Minority Health and Health Disparities","doi-asserted-by":"crossref","award":["ID10-CSULB-008"],"award-info":[{"award-number":["ID10-CSULB-008"]}],"id":[{"id":"10.13039\/100006545","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,9,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Background. \u2003Hepatitis C is one of the most prevalent blood-borne diseases in the United States. Despite the benefits of early screening, among 3.2 million Americans who are infected with hepatitis C virus (HCV), 50%\u201370% are unaware of their infection status.<\/jats:p>\n               <jats:p>Methods. \u2003Data were collected between 2011 and 2014, from 1048 clients who were in the following groups: (1) injection drug users, (2) women at sexual risk, (3) gay and bisexual men, and (4) transgender individuals. The sensitivity and specificity of point-of-care tests included (1) the MedMira rapid human immunodeficiency virus (HIV)\/HCV antibody test, (2) MedMira hepatitis B (HBV)\/HIV\/HCV antibody test, (3) Chembio HCV Screen Assay used with both whole blood and (4) oral specimens, (5) Chembio HIV-HCV Assay also used with both whole blood and (6) oral specimens, (7) Chembio HIV-HCV-Syphilis Assay, and (8) OraSure HCV Rapid Antibody Test used with whole blood. The gold standard for the HCV tests were HCV enzyme immunoassay (EIA) 2.0.<\/jats:p>\n               <jats:p>Results. \u2003OraSure had the highest sensitivity at 92.7% (95% confidence interval [CI] = 88.8%\u201396.5%) followed closely by Chembio's 3 blood tests at 92.1% (95% CI = 87.7%\u201396.4%), 91.5% (95% CI = 87.2%\u201395.7%), and 92.3% (95% CI = 88.4%\u201396.2%). The sensitivities of MedMira HIV\/HCV and MedMira HIV\/HCV\/HBV tests were the lowest, at 79.1% (95% CI = 72.6%\u201385.5%), and 81.5% (95% CI = 75.2%\u201387.8%), respectively. Specificity for the OraSure was 99.8% (95% CI = 99.4%\u2013100%); specificity for the Chembio blood tests was 99.2% (95% CI = 98.6%\u201399.9%), 99.4% (95% CI = 98.8%\u201399.9%), and 99.3% (95% CI = 98.8%\u201399.9%); and specificity for the MedMira was100% and 100%. False-negative results were associated with HIV and hepatitis B core antibody serostatus.<\/jats:p>\n               <jats:p>Conclusions. \u2003The OraSure and Chembio blood tests (including those multiplexed with HIV and syphilis) appear to good performance characteristics. This study has identified potential limitations of rapid testing in those testing positive for HIV and HBcAb. There should be discussion of updates to the 2013 CDC guidance.<\/jats:p>","DOI":"10.1093\/ofid\/ofv101","type":"journal-article","created":{"date-parts":[[2015,8,12]],"date-time":"2015-08-12T00:30:08Z","timestamp":1439339408000},"source":"Crossref","is-referenced-by-count":25,"title":["Comparison of Rapid Point-of-Care Tests for Detection of Antibodies to Hepatitis C Virus"],"prefix":"10.1093","volume":"2","author":[{"given":"Dennis G.","family":"Fisher","sequence":"first","affiliation":[{"name":"Center for Behavioral Research and Services"},{"name":"Psychology Department"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristen L.","family":"Hess","sequence":"additional","affiliation":[{"name":"Center for Behavioral Research and Services"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erlyana","family":"Erlyana","sequence":"additional","affiliation":[{"name":"Center for Behavioral Research and Services"},{"name":"Department of Health Care Administration"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grace L.","family":"Reynolds","sequence":"additional","affiliation":[{"name":"Center for Behavioral Research and Services"},{"name":"Department of Health Care Administration"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine A.","family":"Cummins","sequence":"additional","affiliation":[{"name":"School of Nursing, California State University, Long Beach"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Todd A.","family":"Alonzo","sequence":"additional","affiliation":[{"name":"Department of Preventive Medicine, University of Southern California, Los Angeles"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2015,7,7]]},"reference":[{"key":"2020081009164777500_OFV101C1","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1002\/hep.26194","article-title":"Hepatitis C screening: getting it right","volume":"57","author":"Edlin","year":"2013","journal-title":"Hepatology"},{"key":"2020081009164777500_OFV101C2","doi-asserted-by":"crossref","first-page":"e58975","DOI":"10.1371\/journal.pone.0058975","article-title":"Cost-effectiveness analysis of risk-factor guided and birth-cohort screening for chronic hepatitis C infection in the United States","volume":"8","author":"Liu","year":"2013","journal-title":"PLoS One"},{"issue":"(RR-4)","key":"2020081009164777500_OFV101C3","first-page":"1","article-title":"Recommendations for the identification of chronic hepatitis C virus infection among persons born during 1945\u20131965","volume":"61","author":"Smith","year":"2012","journal-title":"MMWR Recomm Rep"},{"key":"2020081009164777500_OFV101C4","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1093\/infdis\/jir422","article-title":"Evaluation of three rapid screening assays for detection of antibodies to hepatitis C virus","volume":"204","author":"Smith","year":"2011","journal-title":"J Infect Dis"},{"key":"2020081009164777500_OFV101C5","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1111\/j.1365-2893.2010.01327.x","article-title":"Hepatitis C testing practices and prevalence in a high-risk urban ambulatory care setting","volume":"18","author":"Southern","year":"2011","journal-title":"J Viral Hepat"},{"key":"2020081009164777500_OFV101C6","first-page":"548","article-title":"Hepatitis C virus screening practices and prevalence in a managed care organization","volume":"17","author":"Roblin","year":"2011","journal-title":"Am J Managed Care"},{"key":"2020081009164777500_OFV101C7","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.2105\/AJPH.87.10.1722","article-title":"Hepatitis C virus infection among Alaskan drug users","volume":"87","author":"Fisher","year":"1997","journal-title":"Am J Public Health"},{"key":"2020081009164777500_OFV101C8","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1093\/cid\/ciu643","article-title":"Emerging epidemic of hepatitis C virus infections among young nonurban persons who inject drugs in the United State, 2006\u20132012","volume":"59","author":"Suryaprasad","year":"2014","journal-title":"Clin Infect Dis"},{"issue":"(Suppl 1)","key":"2020081009164777500_OFV101C9","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1093\/cid\/cis393","article-title":"Evolving epidemiology of hepatitis C virus in the United States","volume":"55","author":"Klevens","year":"2012","journal-title":"Clin Infect Dis"},{"key":"2020081009164777500_OFV101C10","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1186\/1471-2458-14-830","article-title":"Incidence and correlates of hepatitis C virus infection in a large cohort of prisoners who have injected drugs","volume":"14","author":"Snow","year":"2014","journal-title":"BMC Public Health"},{"key":"2020081009164777500_OFV101C11","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1111\/add.12643","article-title":"A prospective study of hepatitis C incidence in Australian prisoners","volume":"109","author":"Luciani","year":"2014","journal-title":"Addiction"},{"key":"2020081009164777500_OFV101C12","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1016\/j.addbeh.2014.04.020","article-title":"Injection and non-injection drug use and infectious disease in Baltimore City: differences by race","volume":"39","author":"Keen","year":"2014","journal-title":"Addict Behav"},{"key":"2020081009164777500_OFV101C13","doi-asserted-by":"crossref","first-page":"975","DOI":"10.26719\/2013.19.12.975","article-title":"High prevalence of HCV coinfection in HIV-infected individuals in Shiraz, Islamic Republic of Iran","volume":"19","author":"Alipour","year":"2013","journal-title":"East Mediterr Health J"},{"key":"2020081009164777500_OFV101C14","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/2046-4053-3-31","article-title":"Hepatitis C virus infection among HIV-positive men who have sex with men: Protocol for a systematic review and met-analysis","volume":"3","author":"Hagan","year":"2014","journal-title":"Syst Rev"},{"key":"2020081009164777500_OFV101C15","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1001\/archpedi.161.2.125","article-title":"Results of a general hepatitis C lookback program for persons who received blood transfusions in a neonatal intensive care unit between January 1975 and July 1992","volume":"161","author":"Cagle","year":"2007","journal-title":"Arch Pediatr Adolesc Med"},{"key":"2020081009164777500_OFV101C16","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1111\/j.1537-2995.2005.04280.x","article-title":"Results of a hepatitis C general transfusion lookback program for patients who received blood products before July 1992","volume":"45","author":"Williams","year":"2005","journal-title":"Transfusion"},{"key":"2020081009164777500_OFV101C17","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1111\/jgh.12355","article-title":"Targeted hepatitis C screening among ex-injection drug users in the community","volume":"29","author":"Wong","year":"2014","journal-title":"J Gastroenterol Hepatol"},{"key":"2020081009164777500_OFV101C18","first-page":"432","article-title":"Evaluation of rapid kits for detection of HIV, HBsAg and HCV infections","volume":"54","author":"Kaur","year":"2000","journal-title":"Indian J Med Sci"},{"key":"2020081009164777500_OFV101C19","doi-asserted-by":"crossref","first-page":"558","DOI":"10.7326\/0003-4819-157-8-201210160-00006","article-title":"Accuracy of rapid and point-of-care screening tests for hepatitis C: a systematic review and meta-analysis","volume":"157","author":"Shivkumar","year":"2012","journal-title":"Ann Intern Med"},{"key":"2020081009164777500_OFV101C20","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S1473-3099(13)70250-0","article-title":"Diagnostic point-of-care tests in resource-limited settings","volume":"14","author":"Drain","year":"2014","journal-title":"Lancet Infect Dis"},{"issue":"(Supplement 3)","key":"2020081009164777500_OFV101C21","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1177\/00333549081230S308","article-title":"Results from a multiple morbidities testing program offering rapid HIV testing bundled with hepatitis and sexually transmitted infection testing","volume":"123","author":"Reynolds","year":"2008","journal-title":"Public Health Rep"},{"key":"2020081009164777500_OFV101C22","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.jviromet.2010.12.009","article-title":"Evaluation of a new, rapid test for detecting HCV infection, suitable for use with blood or oral fluid","volume":"172","author":"Lee","year":"2011","journal-title":"J Virol Methods"},{"key":"2020081009164777500_OFV101C23","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1477-7517-10-7","article-title":"Hepatitis C treatment access and uptake for people who inject drugs: a review mapping the role of social factors","volume":"10","author":"Harris","year":"2013","journal-title":"Harm Reduct J"},{"key":"2020081009164777500_OFV101C24","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s11414-013-9333-3","article-title":"Increasing hepatitis C knowledge among homeless adults: results of a community-based, interdisciplinary intervention","volume":"41","author":"Tyler","year":"2014","journal-title":"J Behav Health Serv Res"},{"key":"2020081009164777500_OFV101C25","article-title":"Failure to return for HIV, hepatitis, and STI test results in Los Angeles County, California","author":"Brooks","year":"2008"},{"key":"2020081009164777500_OFV101C26","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/528904","article-title":"Successful integration of hepatitis C virus point-of-care tests into the Denver Metro Health Clinic","author":"Jewett","year":"2013","journal-title":"AIDS Res Treat"},{"key":"2020081009164777500_OFV101C27","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1586\/erm.13.13","article-title":"Rapid hepatitis C tests: better than the gold standard?","volume":"13","author":"Pai","year":"2013","journal-title":"Exp Rev Mol Diagn"},{"key":"2020081009164777500_OFV101C28","first-page":"19","article-title":"Rapid and simple hepatitis assays: encouraging results from a blood donor population in Zimbabwe","volume":"74","author":"Mvere","year":"1995","journal-title":"Bull World Health Organ"},{"key":"2020081009164777500_OFV101C29","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1111\/j.1537-2995.2012.03770.x","article-title":"Laboratory evaluation of rapid test kits to detect hepatitis C antibody for use in predonation screening in emergency settings","volume":"53","author":"O'Connell","year":"2013","journal-title":"Transfusion"},{"key":"2020081009164777500_OFV101C30","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1097\/MEG.0b013e32835c502d","article-title":"Evaluation of a rapid on-site anti-HCV test as a screening tool for hepatitis C virus infection","volume":"25","author":"Kant","year":"2013","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"2020081009164777500_OFV101C31","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.jcv.2007.11.002","article-title":"Sensitivity of a rapid immuno-chromatographic test for hepatitis C antibodies detection","volume":"41","author":"Desbois","year":"2008","journal-title":"J Clin Virol"},{"key":"2020081009164777500_OFV101C32","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1093\/cid\/cir499","article-title":"Performance of premarket rapid hepatitis C virus antibody assays in 4 national human immunodeficiency virus behavioral surveillance system sites","volume":"53","author":"Smith","year":"2011","journal-title":"Clin Infect Dis"},{"key":"2020081009164777500_OFV101C33","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.jcv.2013.07.015","article-title":"Anti-hepatitis C virus antibody detection in oral fluid: influence of human immunodeficiency virus co-infection","volume":"58","author":"Visseaux","year":"2013","journal-title":"J Clin Virol"},{"key":"2020081009164777500_OFV101C34","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.jcv.2012.04.003","article-title":"Field-based performance of three pre-market rapid hepatitis C virus antibody assays in STAHR (Study to Assess Hepatitis C Risk) among young adults who inject drugs in San Diego, CA","volume":"54","author":"Jewett","year":"2012","journal-title":"J Clin Virol"},{"issue":"(10 pt 2)","key":"2020081009164777500_OFV101C35","doi-asserted-by":"crossref","first-page":"2525","DOI":"10.1111\/trf.12178","article-title":"Comparative analysis of triplex nucleic acid test assays in United States blood donors","volume":"53","author":"Stramer","year":"2013","journal-title":"Transfusion"},{"key":"2020081009164777500_OFV101C36","article-title":"Classifying skin lesions of injection drug users: a method for corroborating disease risk","volume-title":"U.S. Department of Health and Human Services","author":"Cagle","year":"2002"},{"key":"2020081009164777500_OFV101C37","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1037\/0893-164X.9.4.242","article-title":"Reliability of self-reported HIV risk behaviors of drug users","volume":"9","author":"Needle","year":"1995","journal-title":"Psychol Addict Behav"},{"key":"2020081009164777500_OFV101C38","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1177\/107319119400100407","article-title":"Reliability of drug users\u2019 self-reported HIV risk behaviors and validity of self-reported recent drug use","volume":"1","author":"Dowling-Guyer","year":"1994","journal-title":"Assessment"},{"key":"2020081009164777500_OFV101C39","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1093\/biomet\/26.4.404","article-title":"The use of confidence or fiducial limits illustrated in the case of the binomial","volume":"26","author":"Clopper","year":"1934","journal-title":"Biometrika"},{"key":"2020081009164777500_OFV101C40","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1002\/(SICI)1097-0258(19970615)16:11<1263::AID-SIM550>3.0.CO;2-M","article-title":"A marginal regression modelling framework for evaluating medical diagnostic tests","volume":"16","author":"Leisenring","year":"1997","journal-title":"Stat Med"},{"key":"2020081009164777500_OFV101C41","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1007\/s11524-008-9328-1","article-title":"HIV prevalence rates among injection drug users in 96 large US metropolitan areas, 1992\u20132002","volume":"86","author":"Tempalki","year":"2008","journal-title":"J Urban Health"},{"key":"2020081009164777500_OFV101C42","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.jcv.2008.02.015","article-title":"Validation of a strategy for HCV antibody testing with two enzyme immunoassays in a routine clinical laboratory","volume":"42","author":"Vermeersch","year":"2008","journal-title":". J Clin Virol"},{"key":"2020081009164777500_OFV101C43","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1056\/NEJM199703273361304","article-title":"Simultaneous transmission of human immunodeficiency virus and hepatitis C virus from a needle-stick injury","volume":"336","author":"Ridzon","year":"1997","journal-title":"N Engl J Med"},{"key":"2020081009164777500_OFV101C44","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1046\/j.1537-2995.2001.41030427.x","article-title":"Long-term hepatitis C seroconversion in a blood donor","volume":"41","author":"Bux-Gewehr","year":"2001","journal-title":"Transfusion"},{"key":"2020081009164777500_OFV101C45","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/978-1-59259-702-4_4","article-title":"Hepatitis C virus: biology, pathogenesis, epidemiology, clinical description, and diagnosis","volume-title":"Viral Hepatitis: Diagnosis, Therapy, and Prevention","author":"Bendinelli","year":"1999"},{"key":"2020081009164777500_OFV101C46","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1055\/s-2000-9505","article-title":"Recovery, persistence, and sequelae in hepatitis C virus infection: a perspective on long-term outcome","volume":"20","author":"Alter","year":"2000","journal-title":"Semin Liver Dis"},{"issue":"(RR03)","key":"2020081009164777500_OFV101C47","first-page":"1","article-title":"Guidelines for laboratory testing and result reporting of antibody to hepatitis C virus","volume":"52","author":"Alter","year":"2003","journal-title":"MMWR Recomm Rep"},{"key":"2020081009164777500_OFV101C48","doi-asserted-by":"crossref","first-page":"2987","DOI":"10.1002\/(SICI)1097-0258(19991130)18:22<2987::AID-SIM205>3.0.CO;2-B","article-title":"Using a combination of reference tests to assess the accuracy of a new diagnostic test","volume":"18","author":"Alonzo","year":"1999","journal-title":"Stat Med"},{"key":"2020081009164777500_OFV101C49","first-page":"362","article-title":"Testing for HCV infection: an update of guidance for clinicians and laboratorians","volume":"62","author":"Centers for Disease Control and Prevention (CDC).","year":"2013","journal-title":"MMWR"}],"container-title":["Open Forum Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ofid\/article-pdf\/2\/3\/ofv101\/33621534\/ofv101.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/ofid\/article-pdf\/2\/3\/ofv101\/33621534\/ofv101.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,10]],"date-time":"2020-08-10T13:22:28Z","timestamp":1597065748000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ofid\/article\/doi\/10.1093\/ofid\/ofv101\/2460362"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015]]},"references-count":49,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,9,1]]}},"URL":"https:\/\/doi.org\/10.1093\/ofid\/ofv101","relation":{},"ISSN":["2328-8957"],"issn-type":[{"value":"2328-8957","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2015]]},"published":{"date-parts":[[2015]]},"article-number":"ofv101"}}